Archean Chemical Industries Limited reported its Q1 FY27 financial results on July 30, 2026. Consolidated revenue from operations stood at ₹3,271.98 million, up 11.9% year-on-year, while net profit dropped 24.4% to ₹306.77 million due to increased operational costs and material consumption across expanded subsidiary operations.
CHENNAI — Archean Chemical Industries Limited (ACIL) announced its unaudited standalone and consolidated financial results for the first quarter ended June 30, 2026, on July 30, 2026. According to regulatory filings submitted to the National Stock Exchange of India (NSE) and BSE Limited following a board of directors meeting in Chennai, the leading marine specialty chemical producer reported consolidated revenue from operations of ₹3,271.98 million (₹3.27 billion). The performance reflects an 11.9% growth compared to ₹2,923.59 million generated in the corresponding quarter of the previous financial year. However, elevated material costs and administrative expenses narrowed consolidated net profit after tax to ₹306.77 million (₹306.8 million), down from ₹401.43 million in Q1 FY26.
Detailed Financial Performance and Income Metrics
Under the financial results reviewed by the audit committee and approved by the board under Managing Director Rampraveen Swaminathan, Archean Chemical demonstrated top-line quarterly growth.
Total Consolidated Income: Total consolidated income for the quarter reached ₹3,328.05 million (including other income of ₹56.07 million), expanding from ₹3,005.89 million recorded in Q1 FY26 and ₹3,063.31 million in Q4 FY26.
Standalone Operations: On a standalone basis, revenue from operations reached ₹3,159.33 million compared to ₹2,786.30 million in Q1 FY26. Standalone net profit for the quarter stood at ₹405.28 million, compared to ₹518.49 million in the year-ago period.
Earnings Per Share (EPS): Basic and diluted consolidated earnings per share for the quarter stood at ₹2.48 per share (face value ₹2.00), compared to ₹3.25 in Q1 FY26 and ₹1.13 in Q4 FY26.
Operational Expenditure and Expense Breakdown
The reduction in quarterly margins stemmed primarily from an uptick in operational costs and raw material consumption across domestic and international supply lines.
Consolidated total expenses for Q1 FY27 mounted to ₹2,885.86 million, up significantly from ₹2,425.83 million in the prior-year period. Cost of materials consumed rose to ₹385.00 million from ₹340.61 million in Q1 FY26. Other operational expenses expanded to ₹2,100.33 million compared to ₹1,697.39 million reported in the same quarter of FY26. Depreciation and amortization expenses accounted for ₹232.00 million, while finance costs totaled ₹54.52 million.
Tax expenses for the quarter aggregated to ₹138.65 million on a consolidated basis, following a current tax charge of ₹170.66 million and a deferred tax adjustment.
Strategic Corporate Developments and Subsidiary Filings
In statutory notes accompanying the financial results, Archean Chemical highlighted several key corporate movements and regulatory assessments:
Acume Chemicals Capitalization: The parent company completed a rights issue subscription of ₹1,700 million into its wholly owned subsidiary, Acume Chemicals Private Limited, subscribing to 170 million equity shares on June 17, 2026.
Reverse Merger Status: A scheme of amalgamation involving a reverse merger between subsidiary Idealis Chemicals Private Limited and its step-down subsidiary Idealis Mudchemie Private Limited remains underway under Section 233 of the Companies Act, 2013.
Semiconductor Fiscal Support: Step-down subsidiary SiCSem Private Limited executed a Fiscal Support Agreement with the India Semiconductor Mission and the Government of Odisha, making it eligible for fiscal support covering up to 75% of eligible capital expenditure.
Land Lease Continuity: The company confirmed ongoing engagement with the Government of Gujarat regarding its manufacturing site land lease renewal, maintaining confidence based on state circulars permitting 30-year lease extensions.
Official Sources Section
According to official filings lodged under Regulation 30 and 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the un-audited standalone and consolidated results were reviewed by independent statutory auditors PKF Sridhar & Santhanam LLP.
Official disclosures were transmitted to the listing operations departments of BSE Limited and the National Stock Exchange of India Limited. Further financial policy overviews are monitored via the Ministry of Finance.
Quote Section
"According to officials at Archean Chemical Industries Limited, the company's financial results reflect sustained top-line demand across industrial chemical segments alongside disciplined long-term capital deployments across subsidiary growth initiatives."
Why It Matters
The first-quarter financial update carries key takeaways for equity markets and industrial stakeholders:
For Investors & Analysts: Sequential revenue recovery from Q4 FY26 highlights steady production throughput, though margin compression underscores cost pressure management needs.
For Chemical Industry Markets: Continued investments into specialty bromine and industrial salt derivatives position ACIL for expanded global market share.
For Business Partners & Subsidiaries: Capitalization of Acume Chemicals and fiscal agreements under the India Semiconductor Mission provide long-term capital backing for high-value manufacturing verticals.
Key Facts at a Glance
Consolidated Revenue: ₹3,271.98 million (₹3.27 billion), up 11.9% YoY.
Consolidated Net Profit: ₹306.77 million (₹306.8 million).
Consolidated Basic EPS: ₹2.48 per share (Face value ₹2.00).
Rights Issue Investment: ₹1,700 million invested in Acume Chemicals Private Limited.
Semiconductor Incentive: Step-down entity SiCSem eligible for up to 75% Capex fiscal support from India Semiconductor Mission.
Frequently Asked Questions (FAQ)
What was Archean Chemical's revenue in Q1 FY27?
Archean Chemical reported consolidated revenue from operations of ₹3,271.98 million (₹3.27 billion) for the quarter ended June 30, 2026.
What was the company's net profit for the June quarter?
The consolidated net profit after tax for Q1 FY27 stood at ₹306.77 million (₹306.8 million).
How much did Archean Chemical invest in Acume Chemicals?
The company completed a rights issue subscription of ₹1,700 million (₹170 crore) into its subsidiary, Acume Chemicals Private Limited, on June 17, 2026.
What major government support agreement did SiCSem sign?
Step-down subsidiary SiCSem Private Limited entered into a Fiscal Support Agreement with the India Semiconductor Mission and the Odisha government for up to 75% capital expenditure support.
Sources: Archean Chemical Industries Official Website, Company Disclosure to Stock Exchnages
